Vera Therapeutics: FDA's eGFR Analysis Supports A Speculative Buy (NASDAQ:VERA)
· seekingalpha.com
Vera Therapeutics is upgraded to Buy following TRUTAKNA's FDA approval and encouraging eGFR data. Learn more about VERA stock here.
About the TPT service
Thanks for reading. At the Total Pharma Tracker, we offer most of the following:-
For investors requiring hands-on support, our in-hou...